[go: up one dir, main page]

IL136514A0 - Beta-lipotropin and uses thereof - Google Patents

Beta-lipotropin and uses thereof

Info

Publication number
IL136514A0
IL136514A0 IL13651498A IL13651498A IL136514A0 IL 136514 A0 IL136514 A0 IL 136514A0 IL 13651498 A IL13651498 A IL 13651498A IL 13651498 A IL13651498 A IL 13651498A IL 136514 A0 IL136514 A0 IL 136514A0
Authority
IL
Israel
Prior art keywords
lipotropin
beta
Prior art date
Application number
IL13651498A
Other languages
English (en)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of IL136514A0 publication Critical patent/IL136514A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/67—Lipotropins, e.g. beta, gamma lipotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
IL13651498A 1997-12-23 1998-12-21 Beta-lipotropin and uses thereof IL136514A0 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US6865997P 1997-12-23 1997-12-23
US7985798P 1998-03-30 1998-03-30
US8632198P 1998-05-21 1998-05-21
US9138598P 1998-07-01 1998-07-01
US9540598P 1998-08-05 1998-08-05
US10397698P 1998-10-13 1998-10-13
PCT/US1998/027238 WO1999032142A1 (en) 1997-12-23 1998-12-21 Beta-lipotropin and uses thereof

Publications (1)

Publication Number Publication Date
IL136514A0 true IL136514A0 (en) 2001-06-14

Family

ID=27557000

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13651498A IL136514A0 (en) 1997-12-23 1998-12-21 Beta-lipotropin and uses thereof

Country Status (18)

Country Link
US (2) US6323178B1 (es)
EP (1) EP0926239A3 (es)
JP (1) JP2001526061A (es)
KR (1) KR20010024805A (es)
CN (1) CN1284882A (es)
AR (1) AR018532A1 (es)
AU (1) AU1938599A (es)
BR (1) BR9814433A (es)
CA (1) CA2315888A1 (es)
CO (1) CO4930304A1 (es)
EA (1) EA200000709A1 (es)
HR (1) HRP20000426A2 (es)
HU (1) HUP0100132A2 (es)
IL (1) IL136514A0 (es)
PE (1) PE20000062A1 (es)
PL (1) PL341293A1 (es)
TR (1) TR200002611T2 (es)
WO (1) WO1999032142A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002048337A2 (en) * 2000-12-13 2002-06-20 Incyte Genomics, Inc. Secreted human proteins
US7910101B2 (en) 2004-10-25 2011-03-22 Centocor, Inc. Melanocortin receptor binding mimetibodies, compositions, methods and uses
US8227194B2 (en) * 2005-04-08 2012-07-24 University Of Maryland, Baltimore Monoclonal antibodies with binding specificity for response gene to complement 32 (RGC-32)
US20090281519A1 (en) * 2008-05-12 2009-11-12 Rao R Harsha Automated system and method for diabetes control
CN119161446B (zh) * 2024-11-22 2025-02-14 杭州诺泰诺和生物医药科技有限公司 胰淀素类似物的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4769326A (en) * 1980-02-29 1988-09-06 The Regents Of The University Of California Expression linkers
US5258496A (en) 1990-07-10 1993-11-02 Scios Nova Inc. Isolation and purification of lung surfactant protein
AU692794B2 (en) * 1993-08-30 1998-06-18 Baylor College Of Medicine Senescent cell-derived inhibitors of DNA synthesis
US5478852C1 (en) 1993-09-15 2001-03-13 Sankyo Co Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of impaired glucose tolerance in order to prevent or delay the onset of noninsulin-dependent diabetes mellitus
US5691309A (en) 1995-01-31 1997-11-25 Eli Lilly And Company Anti-obesity proteins

Also Published As

Publication number Publication date
US6323178B1 (en) 2001-11-27
PL341293A1 (en) 2001-04-09
KR20010024805A (ko) 2001-03-26
EP0926239A3 (en) 2002-08-28
TR200002611T2 (tr) 2000-12-21
BR9814433A (pt) 2000-10-10
CA2315888A1 (en) 1999-07-01
PE20000062A1 (es) 2000-02-08
AR018532A1 (es) 2001-11-28
JP2001526061A (ja) 2001-12-18
US20030073621A1 (en) 2003-04-17
HUP0100132A2 (hu) 2001-05-28
CO4930304A1 (es) 2000-06-27
HRP20000426A2 (en) 2000-10-31
EA200000709A1 (ru) 2000-12-25
WO1999032142A1 (en) 1999-07-01
AU1938599A (en) 1999-07-12
EP0926239A2 (en) 1999-06-30
CN1284882A (zh) 2001-02-21

Similar Documents

Publication Publication Date Title
IL128869A0 (en) Pyrozolopyrimidines and pyrazolotriazines
EP1032377A4 (en) SUBSTITUTED 2-AMINOACETAMIDES AND APPLICATION THEREOF
EP1037635A4 (en) CONNECTIONS AROUND METHODS
IL122428A0 (en) Minizymes and minribozymes and uses thereof
HUP0004930A3 (en) Ampoules and manufacture thereof
AU7718898A (en) Txu-7-pap immunotoxin and use thereof
AU9781998A (en) Huchordin and uses thereof
HUP9700446A3 (en) Oilsuspension-concentrate and using thereof
GB9719046D0 (en) Device and assembly
HUP0001603A3 (en) Cycloalkylalkanecarboxamides and the production and use thereof
GB9702354D0 (en) Compounds and their use
HUP0100192A3 (en) Improved stomach-action molluscicides and preparation thereof
PL331523A1 (en) Azolotrizines and azolopyrimidines
ZA964862B (en) Optimized minizymes and miniribozymes and uses thereof
IL136514A0 (en) Beta-lipotropin and uses thereof
IL123535A0 (en) Benzoxazindione derivatives and their use
PL328334A1 (en) Preparation and application thereof
ZA988492B (en) Substituted tetrahydro-naphthalenes and analogous compounds
ZA984896B (en) Carbohydrates and use thereof
GB9714877D0 (en) Microorganism and its use
ZA9811733B (en) Beta-Lipotropin and uses thereof.
IL115853A0 (en) Aryloxycycloalkenyl and aryloxyiminocyclo-alkenylhydroxyureas
ZA988065B (en) Pyrimidin-2-oxy-4-one and pyrimidin-2-oxy-4-thione derivatives
GB9720258D0 (en) Extravise and Inavise
ZA989113B (en) Aminobutanoic and derivatives